Journey to a New Era for Alzheimer’s Disease

2024 brought pivotal advances in neurodegenerative biomarkers for early Alzheimer’s detection, insights into amyloid-targeted therapies and patient selection, and new strategies for ARIA risk assessment and management.

Revisit 2024 Conference Highlights for Alzheimer’s Disease. Watch Experts in Conversation: Highlights from AD/PD and CONy 2024, featuring Dorota Religa (Sweden) and Robert Perneczky (Germany). Take part in all 3 activities by November 30, 2025.

Completing one Expert in Conversation activity will earn you 0.5 AMA PRA Category 1 Credit™. The activity for CTAD is separated into 2 videos and you will need to watch both to earn 0.5. You can earn a total of 1.5 credits for all four activities.